food and drug administration

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…

The use of injectable peptides for a range of perceived health benefits is surging, fueled by aggressive marketing…

Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…

Removing the most dire warning from hormonal therapies to treat menopause is likely the right call, women’s health…

“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” Today, the FDA…

The United States will remove strong safety warnings on many hormone therapies used to alleviate menopausal symptoms, saying…

WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…

More than half a million bottles of a popular blood pressure medication have been recalled because they contain…

The U.S. Food and Drug Administration announced Wednesday that it will relax certain rules for approving low-cost versions…

More than half a million bottles of a popular blood pressure medication have been recalled because they contain…

Check your medicine cabinet. More than 140,000 bottles of a commonly prescribed statin have been recalled due to…

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease